The Enosis Santé association was created in 2022 by 4 French healthcare clusters: BioValley France, Eurobiomed, Lyonbiopole Auvergne-Rhône-Alpes and Medicen Paris Region.
Through increased inter-cluster synergies, Enosis Santé aims to boost each cluster’s capacity to accelerate the development of healthtech innovation, support innovative companies and reinforce France’s leadership in healthcare.
Thanks to its close links with regional health innovation stakeholders, who are members of each cluster, and its involvement with the French government, Enosis Santé combines regional initiatives with the structuring of national strategic sectors.
One of its key objectives is to actively contribute to the French Health Innovation 2030 Plan.
Operate France 2030 and act as the regional helping hand of the Agence de l’Innovation en Santé (AIS).
Pool resources and services to deliver coordinated, high-impact initiatives
Collaborate with other players in the healthcare sector (other clusters, unions, etc.) to optimize actions in favor of innovation in healthcare.
Represent the interests of innovation players (start-ups, T/SMEs, mid-caps, large companies, academic and clinical structures) and regional ecosystems.
Promote the results of the work of clusters and their ecosystems
Strength of established networks
Strength of established networks
In-depth knowledge of companies and regional ecosystems that account for 80% of innovation projects in France
In-depth knowledge of companies and regional ecosystems that account for 80% of innovation projects in France
Coordination of inter-clusters actions in strategic areas: Innovation, International, Business development support, Europe & Communication
Coordination of inter-clusters actions in strategic areas: Innovation, International, Business development support, Europe & Communication
Working in synergy with key structures such as the Conseil Stratégique des Industries de Santé (CSIS), the Agence de l’Innovation en Santé (AIS), the Direction Générale des Entreprises, the Comité Stratégique de Filières des Industries et Technologies de Santé, France BioLead…
Working in synergy with key structures such as the Conseil Stratégique des Industries de Santé (CSIS), the Agence de l’Innovation en Santé (AIS), the Direction Générale des Entreprises, the Comité Stratégique de Filières des Industries et Technologies de Santé, France BioLead…
Pooling the expertise of founding cluster teams on cross-functional issues to optimize processes and actions for the benefit of ecosystems
Pooling the expertise of founding cluster teams on cross-functional issues to optimize processes and actions for the benefit of ecosystems
public and private players, including
+ 1,200 innovative companies
public and private players, including
+ 1,200 innovative companies
supported since 2005, representing over €5 billion in investment and resulting in the launch of more than 230 products or services
supported since 2005, representing over €5 billion in investment and resulting in the launch of more than 230 products or services
raised in 2022 by companies belonging to the 4 clusters
raised in 2022 by companies belonging to the 4 clusters
Please visit the french version of our website to see our news and events
Comprised of representatives from the 4 founding clusters, the association’s governing bodies are tightly-knit. The chairmanship of the Board of Directors rotates between the cluster presidents for a period of one year. The current chairman of Enosis Santé is Christian Deleuze, President of Medicen, and the vice-chairman is Stephan Jenn, Chairman of Biovalley France.
Christian Deleuze
President
Stéphan Jenn
Vice President